{
    "xml": "<topic id=\"PHP78955\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/tiopex\" basename=\"tiopex\" title=\"Tiopex\">\n<title>Tiopex<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP79012\" outputclass=\"indicationsAndDose\" rev=\"1.12\" parent=\"/clinical-medicinal-product-information/tiopex\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Reduction of intra-ocular pressure in primary open-angle glaucoma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the eye</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply once daily, to be applied in the morning.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP79113\" outputclass=\"nationalFunding\" rev=\"1.8\" parent=\"/clinical-medicinal-product-information/tiopex\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (February 2014) that timolol gel eye drops (<i>Tiopex</i>\n<tm tmtype=\"reg\"/>) are accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure in patients with ocular hypertension or chronic open angle glaucoma who have proven sensitivity to preservatives.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP78955",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/tiopex",
    "basename": "tiopex",
    "title": "Tiopex",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Reduction of intra-ocular pressure in primary open-angle glaucoma",
                        "html": "Reduction of intra-ocular pressure in primary open-angle glaucoma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the eye"
                    ],
                    "textContent": "To the eye",
                    "html": "To the eye"
                },
                "adult": [
                    {
                        "textContent": "Apply once daily, to be applied in the morning.",
                        "html": "<p>Apply once daily, to be applied in the morning.</p>"
                    }
                ]
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (February 2014) that timolol gel eye drops (Tiopex ) are accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure in patients with ocular hypertension or chronic open angle glaucoma who have proven sensitivity to preservatives.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (February 2014) that timolol gel eye drops (<i>Tiopex</i> <tm tmtype=\"reg\"/>) are accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure in patients with ocular hypertension or chronic open angle glaucoma who have proven sensitivity to preservatives.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}